Verastem Inc (NASDAQ:VSTM) Derails Following A Miserable Clinical Failure
[[tagnumber 0]][[tagnumber 1]]In an industry that is as intensely competitive as the biopharmaceutical sector, discovering the right drug for a so far unmet medical need is the key to success. Verastem Inc (NASDAQ:VSTM), a...